{ "cik": 1178670, "cik_padded": "0001178670", "entityName": "ALNYLAM PHARMACEUTICALS, INC.", "fiscal_years": [ { "accn": "0001628280-26-007497", "filed": "2026-02-12", "fiscal_year": 2025, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 58697000.0, "cash": 1657250000.0, "eps_diluted": 2.33, "free_cash_flow": 465383000.0, "net_income": 313747000.0, "operating_cash_flow": 524080000.0, "operating_income": 501578000.0, "revenue": 3713937000.0, "stockholders_equity": 789176000.0, "total_assets": 4966331000.0, "total_liabilities": 4177155000.0 }, "period_end": "2025-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 5.293058836051781, "net_margin": 0.08447827736442487, "operating_margin": 0.13505291015975768, "revenue_growth_yoy": 0.6519286393864009, "roa_avg2y": 0.06815909168425062, "roa_period_end": 0.06317480651209112, "roe_avg2y": 0.7328277260284212, "roe_period_end": 0.3975627743367766 } }, { "accn": "0001628280-26-007497", "filed": "2026-02-12", "fiscal_year": 2024, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 34277000.0, "cash": 966428000.0, "eps_diluted": -2.18, "free_cash_flow": -42589000.0, "net_income": -278157000.0, "operating_cash_flow": -8312000.0, "operating_income": -176885000.0, "revenue": 2248243000.0, "stockholders_equity": 67088000.0, "total_assets": 4239983000.0, "total_liabilities": 4172895000.0 }, "period_end": "2024-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 62.20031898402099, "net_margin": -0.12372194642660958, "operating_margin": -0.07867699354562652, "revenue_growth_yoy": 0.22969580351497462, "roa_avg2y": -0.06893722978940287, "roa_period_end": -0.06560332906995146, "roe_avg2y": 3.6228737398734014, "roe_period_end": -4.146151323634629 } }, { "accn": "0001628280-26-007497", "filed": "2026-02-12", "fiscal_year": 2023, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 62211000.0, "cash": 812688000.0, "eps_diluted": -3.52, "free_cash_flow": 41945000.0, "net_income": -440242000.0, "operating_cash_flow": 104156000.0, "operating_income": -282175000.0, "revenue": 1828292000.0, "stockholders_equity": -220644000.0, "total_assets": 3829880000.0, "total_liabilities": 4050524000.0 }, "period_end": "2023-12-31", "ratio_units": { "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio" }, "ratios": { "net_margin": -0.24079414010453473, "operating_margin": -0.15433803790641756, "revenue_growth_yoy": 0.7623484458530698, "roa_avg2y": -0.11936760725892966, "roa_period_end": -0.11494929345044752, "roe_avg2y": 2.323992324483262 } }, { "accn": "0001628280-26-007497", "filed": "2026-02-12", "fiscal_year": 2022, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 72059000.0, "cash": 866394000.0, "eps_diluted": -9.3, "free_cash_flow": -613333000.0, "net_income": -1131156000.0, "operating_cash_flow": -541274000.0, "operating_income": -785072000.0, "revenue": 1037418000.0, "stockholders_equity": -158223000.0, "total_assets": 3546359000.0, "total_liabilities": 3704582000.0 }, "period_end": "2022-12-31", "ratio_units": { "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio" }, "ratios": { "net_margin": -1.0903570209886468, "operating_margin": -0.7567557146685329, "revenue_growth_yoy": 0.22875041307043695, "roa_avg2y": -0.31466175813803793, "roa_period_end": -0.31896263181477114, "roe_avg2y": -5.261435415600726 } }, { "accn": "0001178670-25-000026", "filed": "2025-02-13", "fiscal_year": 2021, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 76372000.0, "cash": 819975000.0, "eps_diluted": -7.2, "free_cash_flow": -718065000.0, "net_income": -852824000.0, "operating_cash_flow": -641693000.0, "operating_income": -708652000.0, "revenue": 844287000.0, "stockholders_equity": 588203000.0, "total_assets": 3643304000.0, "total_liabilities": 3055101000.0 }, "period_end": "2021-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 5.193956848230968, "net_margin": -1.010111490523957, "operating_margin": -0.8393496524286173, "revenue_growth_yoy": 0.7130604865953946, "roa_avg2y": -0.24192336141462178, "roa_period_end": -0.23407983522648673, "roe_avg2y": -1.0630733273084234, "roe_period_end": -1.4498803984338737 } }, { "accn": "0001178670-24-000008", "filed": "2024-02-15", "fiscal_year": 2020, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 70361000.0, "cash": 496580000.0, "eps_diluted": -7.46, "free_cash_flow": -685322000.0, "net_income": -858281000.0, "operating_cash_flow": -614961000.0, "operating_income": -828438000.0, "revenue": 492853000.0, "stockholders_equity": 1016247000.0, "total_assets": 3407061000.0, "total_liabilities": 2390814000.0 }, "period_end": "2020-12-31", "ratio_units": { "leverage": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 2.3525914467644187, "revenue_growth_yoy": 1.2427895335608645, "roa_avg2y": -0.29584700272913955, "roa_period_end": -0.2519124254012476, "roe_avg2y": -0.6992279645237621, "roe_period_end": -0.8445594427339023 } }, { "accn": "0001178670-23-000005", "filed": "2023-02-23", "fiscal_year": 2019, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 140156000.0, "cash": 547178000.0, "eps_diluted": -8.11, "free_cash_flow": -418583000.0, "net_income": -886116000.0, "operating_cash_flow": -278427000.0, "operating_income": -939431000.0, "revenue": 219750000.0, "stockholders_equity": 1438692000.0, "total_assets": 2395134000.0, "total_liabilities": 956442000.0 }, "period_end": "2019-12-31", "ratio_units": { "leverage": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.6647996930545246, "revenue_growth_yoy": 1.9335985475516633, "roa_avg2y": -0.4464132419263182, "roa_period_end": -0.3699651042488646, "roe_avg2y": -0.6466449468138479, "roe_period_end": -0.6159177919943949 } }, { "accn": "0001178670-22-000013", "filed": "2022-02-10", "fiscal_year": 2018, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 126887000.0, "cash": 420146000.0, "free_cash_flow": -689503000.0, "net_income": -761497000.0, "operating_cash_flow": -562616000.0, "operating_income": -814673000.0, "revenue": 74908000.0, "stockholders_equity": 1301965000.0, "total_assets": 1574802000.0, "total_liabilities": 272837000.0 }, "period_end": "2018-12-31", "ratio_units": { "leverage": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.209557860618373, "revenue_growth_yoy": -0.1668742770709138, "roa_avg2y": -0.426664896126439, "roa_period_end": -0.4835509479921921, "roe_avg2y": -0.4963485808220321, "roe_period_end": -0.5848828501534219 } }, { "accn": "0001564590-19-003022", "filed": "2021-02-11", "fiscal_year": 2017, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 104209000.0, "cash": 645361000.0, "free_cash_flow": -486995000.0, "net_income": -490874000.0, "operating_cash_flow": -382786000.0, "operating_income": -500088000.0, "revenue": 89912000.0, "stockholders_equity": 1766431000.0, "total_assets": 1994730000.0, "total_liabilities": 228299000.0 }, "period_end": "2017-12-31", "ratio_units": { "leverage": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.12924308959704625, "revenue_growth_yoy": 0.9065713861617083, "roa_avg2y": -0.30137711279063345, "roa_period_end": -0.24608543512154527, "roe_avg2y": -0.36541688316908927, "roe_period_end": -0.2778902770614873 } }, { "accn": "0001564590-19-003022", "filed": "2020-02-13", "fiscal_year": 2016, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 64557000.0, "cash": 193617000.0, "free_cash_flow": -372258000.0, "net_income": -410108000.0, "operating_cash_flow": -307701000.0, "operating_income": -424587000.0, "revenue": 47159000.0, "stockholders_equity": 920221000.0, "total_assets": 1262810000.0, "total_liabilities": 342589000.0 }, "period_end": "2016-12-31", "ratio_units": { "leverage": "ratio", "roa_period_end": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.37228991731334105, "roa_period_end": -0.3247582771755054, "roe_period_end": -0.4456625093319974 } } ], "latest_filing": { "accn": "0001628280-26-007497", "filed": "2026-02-12", "form": "10-K" }, "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.", "schema_version": "1", "sic": "2834", "sic_description": "Pharmaceutical Preparations", "source_urls": { "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001178670.json", "sec_submissions": "https://data.sec.gov/submissions/CIK0001178670.json" }, "ticker": "ALNY" }